focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

3rd Quarter Results

7 Jan 2022 13:00

3rd Quarter Results

Oxford Technology 4 VCT Plc – 3rd Quarter Results

Oxford Technology 4 VCT Plc presents its quarterly update for the 3 month period commencing 1 September 2021. The Directors have recently reviewed the valuation of its entire portfolio as at 30 November 2021. The unaudited net asset value per ordinary share as at 30 November 2021 was 41.7p. This represents an increase of 10.7p from the net asset value per ordinary share at 31 August 2021. This increase is mainly attributable to the rise in share price of Arecor Therapeutics Plc (230p to 380p). The total return to shareholders including previous dividends of 48.0p per share is now 89.7p per share. The total number of ordinary shares in issue is 11,516,946. The Directors are not aware of any other events or transactions which have taken place between 30 November 2021 and the publication of this statement which have had a material effect on the financial position of the Company. This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain.

7 January 2022 Enquiries: Lucius CaryOxford Technology Management 01865 784466

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.